Skip to main content
Clinical Trials/JPRN-UMIN000025908
JPRN-UMIN000025908
Completed
未知

Retrospective cohort study of correlation between immune check point molecular inhibitor and response factor, side effect, and post treatment - The rerashonship between immune check point molecular inhibitor and response factor, side effect, or post treatment

Osaka Medical Center for Cancer and Cardiovascular0 sites200 target enrollmentJanuary 31, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Osaka Medical Center for Cancer and Cardiovascular
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Sponsor
Osaka Medical Center for Cancer and Cardiovascular

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who have previously received nivolumab in a clinical trial will be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials